In transgenic mouse models of AD, treatment resulted in a dense distribution of NeuN-immunoreactive cells, particularly concentrated in the outer layers of the entorhinal cortex, suggesting a neuroprotective effect on cortical neuronal development. The gene discussed is RBFOX3; the disease is Alzheimer disease.